Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USAWOS

    Koichi Nishi
    Koichi Nishi
    Rongchang Chen
    Rongchang Chen
    Samir Arora
    Samir Arora
    Andrea Maes
    Andrea Maes
    Shahid Siddiqui
    Shahid Siddiqui
    Colin Reisner
    Colin Reisner
    Cited by: 1|Bibtex|12|

    International journal of chronic obstructive pulmonary disease, Volume 132018, Pages 2969-2984.

    Keywords:
    COPDbronchodilatorco-suspension delivery technologymuscarinic antagonistβ2-agonist

    Abstract:

    These results demonstrated the efficacy of GFF MDI in patients with moderate-to-very severe COPD. GFF MDI was well tolerated, with a safety profile commensurate with long-acting bronchodilators.
    Your rating :
    0

     

    Tags
    Comments